THC Global Group (THC) Stock Price, News & Analysis

Company Overview

THC Global Group Limited provides medicinal cannabis products to patients in Australia and internationally. The company operates through two segments, Manufacture and Distribution of Hydroponics Equipment, Materials and Nutrients; and Development and Delivery of Medicinal Cannabis. Its hydroponics products include lighting and power supplies, lighting relays and climate controls, ventilation and trimming products, extraction bags, plant rotation systems, eyewear, nutrients and accessories, etc. THC Global Group Limited has a strategic alliance with BOL Pharma-Israel; strategic partnership with Ascent Industries CorpÂ-Canada, Sinapse and Pharma programs, and Anspec; distribution agreement with Endoca-Europe; and partnership with Medicinal Cannabis Industry Australia. The company was formerly known as The Hydroponics Company Limited and changed its name to THC Global Group Limited in November 2018. THC Global Group Limited was founded in 2016 and is based in Sydney, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 555,224 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

THC Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of THC Global Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that THC Global Group investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR) and Advanced Emissions Solutions (ADES).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Industrials
• Industry: Farm & Heavy Construction Machinery
• Sub-Industry: Healthcare
• Current Symbol: ASX:THC
• CUSIP: N/A
• CIK: N/A
• Web: thc.global
• Phone: 61 2 9251 7177
• Fax: N/A
• Employees: 102,400
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 18.16
• Current Ratio: 6.12
• Quick Ratio: 4.78

Sales & Book Value

• Annual Sales: $6.14 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 12.60
• Book Value: A$0.16 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 189,456,992
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A